Dyne Therapeutics
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -521 | -500 | -502 | |
EBITDA | -101,229 | -104,614 | -110,260 | -121,870 |
EBIT | -101,750 | -105,137 | -110,763 | -122,372 |
Net Income | -111,955 | -108,041 | -110,857 | -115,361 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -112,316 | -109,964 | -94,763 | -106,874 |
Cash | 893,369 | 573,610 | 485,040 | 472,255 |
Basic Shares | 128,442 | 141,810 | 113,873 | 109,912 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -2,049 | -2,243 | -2,461 | -3,345 |
EBITDA | -437,973 | -315,175 | -233,476 | -169,279 |
EBIT | -440,022 | -317,418 | -235,937 | -170,962 |
Net Income | -446,214 | -317,418 | -235,937 | -165,237 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -405,127 | -294,745 | -188,887 | -156,712 |
Cash | 893,369 | 435,449 | 121,626 | 172,147 |
Basic Shares | 128,442 | 94,144 | 59,683 | 51,976 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$0.73 |
2025-09-30 | -$0.76 |
2025-06-30 | -$0.97 |
